Anika Therapeutics, Inc. (ANIK)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 366.11M |
| Enterprise value | 325.96M |
| Trailing P/E | 43.00 |
| Forward P/E | 22.88 |
| PEG ratio (5-yr expected) | 2.29 |
| Price/sales (ttm) | 2.14 |
| Price/book (mrq) | 1.76 |
| Enterprise value/revenue | 1.93 |
| Enterprise value/EBITDA | -72.65 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.73 |
| 52-week change 3 | -9.79% |
| S&P500 52-week change 3 | 25.26% |
| 52-week high 3 | 28.67 |
| 52-week low 3 | 16.54 |
| 50-day moving average 3 | 25.82 |
| 200-day moving average 3 | 22.33 |
Share statistics
| Avg vol (3-month) 3 | 78.11k |
| Avg vol (10-day) 3 | 54.61k |
| Shares outstanding 5 | 14.83M |
| Implied shares outstanding 6 | 14.83M |
| Float 8 | 10.93M |
| % held by insiders 1 | 2.97% |
| % held by institutions 1 | 91.40% |
| Shares short (30 Apr 2024) 4 | 808.11k |
| Short ratio (30 Apr 2024) 4 | 14.2 |
| Short % of float (30 Apr 2024) 4 | 7.53% |
| Short % of shares outstanding (30 Apr 2024) 4 | 5.45% |
| Shares short (prior month 28 Mar 2024) 4 | 770.4k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -45.39% |
| Operating margin (ttm) | -23.67% |
Management effectiveness
| Return on assets (ttm) | -1.81% |
| Return on equity (ttm) | -31.61% |
Income statement
| Revenue (ttm) | 169.26M |
| Revenue per share (ttm) | 11.54 |
| Quarterly revenue growth (yoy) | 6.90% |
| Gross profit (ttm) | N/A |
| EBITDA | 3.99M |
| Net income avi to common (ttm) | -76.83M |
| Diluted EPS (ttm) | -5.24 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 68.63M |
| Total cash per share (mrq) | 4.63 |
| Total debt (mrq) | 28.47M |
| Total debt/equity (mrq) | 13.65% |
| Current ratio (mrq) | 5.59 |
| Book value per share (mrq) | 14.07 |
Cash flow statement
| Operating cash flow (ttm) | 1.7M |
| Levered free cash flow (ttm) | 6.54M |
© 2024 Yahoo. All rights reserved.